Cubist Systematic Strategies’s Clearside Biomedical CLSD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-16,042
| Closed | -$20.4K | – | 1613 |
|
2024
Q3 | $20.4K | Buy |
+16,042
| New | +$20.4K | ﹤0.01% | 1320 |
|
2024
Q2 | – | Sell |
-24,570
| Closed | -$37.6K | – | 1646 |
|
2024
Q1 | $37.6K | Buy |
+24,570
| New | +$37.6K | ﹤0.01% | 1948 |
|
2022
Q2 | – | Sell |
-19,200
| Closed | -$44K | – | 3838 |
|
2022
Q1 | $44K | Sell |
19,200
-33,747
| -64% | -$77.3K | ﹤0.01% | 3381 |
|
2021
Q4 | $146K | Sell |
52,947
-27,020
| -34% | -$74.5K | ﹤0.01% | 3113 |
|
2021
Q3 | $480K | Buy |
79,967
+53,311
| +200% | +$320K | 0.01% | 2063 |
|
2021
Q2 | $130K | Buy |
26,656
+6,056
| +29% | +$29.5K | ﹤0.01% | 2680 |
|
2021
Q1 | $51K | Buy |
+20,600
| New | +$51K | ﹤0.01% | 2732 |
|
2018
Q4 | – | Sell |
-8,599
| Closed | -$53K | – | 2076 |
|
2018
Q3 | $53K | Buy |
8,599
+8,199
| +2,050% | +$50.5K | ﹤0.01% | 1683 |
|
2018
Q2 | $4K | Sell |
400
-11,871
| -97% | -$119K | ﹤0.01% | 1743 |
|
2018
Q1 | $132K | Buy |
+12,271
| New | +$132K | 0.01% | 1535 |
|